memantine has been researched along with amphetamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gianutsos, G; Hane, JT; Henkel, JG | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dinse, HR; Pleger, B; Ragert, P; Schwenkreis, P; Tegenthoff, M | 1 |
Abraini, JH; Ansseau, M; David, HN; Lemaire, M | 1 |
Bristow, RE; Grahame, NJ; Heighton, ME; Oberlin, BG | 1 |
Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH | 1 |
Gawel, K; Gibula-Bruzda, E; Jenda, M; Kotlinska, JH; Marszalek-Grabska, M | 1 |
1 review(s) available for memantine and amphetamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for memantine and amphetamine
Article | Year |
---|---|
Pharmacological modulation of perceptual learning and associated cortical reorganization.
Topics: Adult; Amphetamine; Brain Mapping; Discrimination Learning; Electric Stimulation; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Female; Humans; Long-Term Potentiation; Male; Memantine; Middle Aged; Neuronal Plasticity; Perception; Receptors, N-Methyl-D-Aspartate; Somatosensory Cortex; Touch | 2003 |
6 other study(ies) available for memantine and amphetamine
Article | Year |
---|---|
Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution.
Topics: Amantadine; Animals; Antiparkinson Agents; Mice; Motor Activity; Receptors, Dopamine; Structure-Activity Relationship | 1982 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Memantine; Motor Activity; Nitrous Oxide; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Time Factors; Xenon | 2006 |
Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice.
Topics: Alcohol Drinking; Alcoholism; Amphetamine; Animals; Behavior, Addictive; Choice Behavior; Female; Impulsive Behavior; Male; Memantine; Mice; Naltrexone; Reaction Time | 2010 |
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ligands; Male; Memantine; Pyridines; Rats; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles | 2013 |
Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antidepressive Agents; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Imipramine; Male; Memantine; Memory Disorders; Muscarinic Antagonists; Nootropic Agents; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Scopolamine; Substance Withdrawal Syndrome | 2016 |